NHSL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.019400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.060800E-01
Normal-vs-Stage2
8.887000E-01
Normal-vs-Stage3
4.222800E-01
Normal-vs-Stage4
8.406000E-01
Stage1-vs-Stage2
6.852200E-01
Stage1-vs-Stage3
3.873200E-01
Stage1-vs-Stage4
8.128800E-01
Stage2-vs-Stage3
2.933400E-01
Stage2-vs-Stage4
8.918400E-01
Stage3-vs-Stage4
2.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.442400E-01
Normal-vs-AfricanAmerican
3.915600E-01
Normal-vs-Asian
8.044400E-01
Caucasian-vs-AfricanAmerican
1.425220E-01
Caucasian-vs-Asian
9.941600E-01
AfricanAmerican-vs-Asian
8.519800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.853600E-01
Normal-vs-Female
7.046200E-01
Male-vs-Female
3.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.821200E-01
Normal-vs-Age(41-60Yrs)
9.992200E-01
Normal-vs-Age(61-80Yrs)
7.654200E-01
Normal-vs-Age(81-100Yrs)
5.808000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.699600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.894200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.094200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.754200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.761680E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.109600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.033400E-01
Normal-vs-Daily Drinker
3.890400E-01
Normal-vs-Weekly Drinker
7.750800E-01
Normal-vs-Occasional Drinker
6.270400E-01
Normal-vs-Social Drinker
8.010000E-01
Non Drinker-vs-Daily Drinker
1.717600E-01
Non Drinker-vs-Weekly Drinker
9.951000E-01
Non Drinker-vs-Occasional Drinker
1.491040E-01
Non Drinker-vs-Social Drinker
9.206800E-01
Daily Drinker-vs-Weekly Drinker
2.083400E-01
Daily Drinker-vs-Occasional Drinker
8.129600E-01
Daily Drinker-vs-Social Drinker
3.154400E-01
Weekly Drinker-vs-Occasional Drinker
1.514430E-01
Weekly Drinker-vs-Social Drinker
9.304000E-01
Occasional Drinker-vs-Social Drinker
3.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.001600E-01
Normal-vs-Grade 2
1.365210E-01
Normal-vs-Grade 3
1.773980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.395600E-01
Grade 1-vs-Grade 3
2.917800E-01
Grade 1-vs-Grade 4
4.001600E-01
Grade 2-vs-Grade 3
8.808800E-01
Grade 2-vs-Grade 4
1.365210E-01
Grade 3-vs-Grade 4
1.773980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.622600E-01
Normal-vs-NonDiabetic
6.843000E-01
Diabetic-vs-NonDiabetic
7.399400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.721400E-01
Normal-vs-NoPancreatitis
6.096000E-01
Pancreatitis-vs-NoPancreatitis
2.839400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.780200E-01
Normal-vs-N1
9.191400E-01
N0-vs-N1
1.382570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.742600E-01
Normal-vs-TP53-NonMutant
9.396600E-01
TP53-Mutant-vs-TP53-NonMutant
7.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
